- Home
- OBT vs VNDA Comparison
OBT vs VNDA Comparison
Compare OBT & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- VNDA
- Stock Information
- Founded
- OBT 1892
- VNDA 2002
- Country
- OBT United States
- VNDA United States
- Employees
- OBT N/A
- VNDA N/A
- Industry
- OBT Major Banks
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- OBT Finance
- VNDA Health Care
- Exchange
- OBT Nasdaq
- VNDA Nasdaq
- Market Cap
- OBT 267.9M
- VNDA 237.9M
- IPO Year
- OBT N/A
- VNDA 2006
- Fundamental
- Price
- OBT $23.53
- VNDA $4.33
- Analyst Decision
- OBT Buy
- VNDA Strong Buy
- Analyst Count
- OBT 1
- VNDA 2
- Target Price
- OBT $35.50
- VNDA $16.50
- AVG Volume (30 Days)
- OBT 17.9K
- VNDA 754.6K
- Earning Date
- OBT 04-30-2025
- VNDA 05-07-2025
- Dividend Yield
- OBT 2.08%
- VNDA N/A
- EPS Growth
- OBT N/A
- VNDA N/A
- EPS
- OBT 2.47
- VNDA N/A
- Revenue
- OBT $100,028,000.00
- VNDA $198,772,000.00
- Revenue This Year
- OBT $12.69
- VNDA $14.36
- Revenue Next Year
- OBT $6.00
- VNDA $44.53
- P/E Ratio
- OBT $9.54
- VNDA N/A
- Revenue Growth
- OBT 6.48
- VNDA 3.18
- 52 Week Low
- OBT $20.97
- VNDA $3.85
- 52 Week High
- OBT $33.06
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- OBT 52.01
- VNDA 43.42
- Support Level
- OBT $21.07
- VNDA $4.27
- Resistance Level
- OBT $22.24
- VNDA $4.46
- Average True Range (ATR)
- OBT 1.13
- VNDA 0.22
- MACD
- OBT 0.07
- VNDA 0.01
- Stochastic Oscillator
- OBT 76.19
- VNDA 54.55
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.